3 The takeaway: Behavior change matters to people on GLP-1s, and the Noom app continues to be associated with stronger real-world GLP-1 outcomes Taken together, these findings tell a clear story: people who pair GLP-1 medication with consistent engagement in the Noom app see more success at weight loss, and, independently, they stay with the program longer
Take readings at the same time each day, usually in the morning before taking medications
The combination of weight loss, improved insulin sensitivity, and direct GLP-1R effects on hepatic lipid metabolism drives these improvements
For customers comparing modern incretin research materials, Retatrutide sits in a different category from single GLP-1 analogues such as Semaglutide and dual agonists such as Tirzepatide
As with many things, there are levels of dedication to biohacking